17 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
Statements iv PART I Item 1. Business 1 Item 1A. Risk Factors 52 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 105 Item 2. Properties 106 … of cybersecurity incidents are being reported, during which certain organizations gain access to databases that contain clinical trial data and demand a ransom
8-K
EX-1.1
CRBU
Caribou Biosciences Inc
14 Jul 23
Caribou Biosciences Announces Proposed Public Offering of Common Stock
6:33pm
to the use of such data from such sources.
(xxxvi) Cybersecurity and Data Protection. (A) There has been no security breach or incident, unauthorized
8-K
EX-10.1
CRBU
Caribou Biosciences Inc
6 Jul 23
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
8:01am
of the Company or any Subsidiary, threatened.
(aj)Cybersecurity and Data Protection. (i) There has been no security breach or incident, unauthorized access
ARS
bokqk69dh 2txhf658
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
l8las4e6b0t r2rjl
11 Aug 22
Definitive proxy
4:04pm
S-3
EX-1.2
lxe1g9vgtngc4ruyyh2t
9 Aug 22
Shelf registration
12:00am
10-K
hu5 5hew70
21 Mar 22
Annual report
4:19pm
424B4
nq5e4
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
EX-1.1
0rd3ummm
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
xyt6ki6t
19 Jul 21
IPO registration (amended)
6:09am
S-1
87e qfzpx
1 Jul 21
IPO registration
4:05pm
DRS/A
s4bnn26axa0ab
11 Jun 21
Draft registration statement (amended)
12:00am
DRS
bkorrpt
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next